Aceto

New York, United States Founded: 1947 • Age: 79 yrs
APIs, intermediates, formulations, and chemicals are manufactured and distributed.

About Aceto

Aceto is a company based in New York (United States) founded in 1947.. Aceto has completed 8 acquisitions, including A&C, A&C Bio Buffer and Biotron Laboratories. Aceto offers products and services including Analytical Services, GMP Contract Manufacturing, and R&D Services. Aceto operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.

  • Headquarter New York, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aceto Pharma (India) Private Limited
  • Date of Incorporation 29 Jan, 2007
  • Jurisdiction Sanand, Gujarat, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $42.29 M (USD)
    19.24
    as on Mar 31, 2023
  • Net Profit
    $8.14 M (USD)
    107.06
    as on Mar 31, 2023
  • EBITDA
    $11.08 M (USD)
    90.59
    as on Mar 31, 2023
  • Latest Funding Round
    $144 M (USD), Post-IPO

    Nov 11, 2015

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    A&C

    & 7 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Aceto

Aceto is a publicly listed company on the NASDAQ with ticker symbol ACET in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: ACET . Sector: Health technology · USA

Products & Services of Aceto

Aceto offers a comprehensive portfolio of products and services, including Analytical Services, GMP Contract Manufacturing, and R&D Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Offers testing for raw materials in multiple industries

Provides contract production of APIs and intermediates

Delivers custom research and scale-up for ingredient solutions

People of Aceto
Headcount 200-500
Employee Profiles 69
Board Members and Advisors 4
Employee Profiles
People
Rajesh Patel
Business Development Director - Cosmetic
People
Larry Fertel
Research Director
People
Raj Gupta
Director Quality & Regulatory- APAC
People
Amit Maheshwari
President, Finar

Unlock access to complete

Board Members and Advisors
people
Chris O'Connell
Board Member
people
Lori Koch
Board Member
people
Salvatore Guccione
Board Member
people
Rakesh Sachdev
Chairman

Unlock access to complete

Funding Insights of Aceto

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $144.0M
  • First Round

    (11 Nov 2015)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2015 Amount Post-IPO - Aceto Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Aceto

Aceto has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include A&C, A&C Bio Buffer and Biotron Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
GMP biological buffers, cleaning solutions, and related products are manufactured.
2018
Mineral ingredient consulting services are provided to industry clients.
2014
Pharmaceutical, agrochemical, aroma, and polymer chemicals are manufactured and supplied.
2004
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Aceto

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aceto Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aceto

Aceto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs and peptides are developed and manufactured by Asymchem.
domain founded_year HQ Location
Contract manufacturing services for small molecules and peptides are provided.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
domain founded_year HQ Location
Contract research and development services for small molecules are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Aceto

When was Aceto founded?

Aceto was founded in 1947 and raised its 1st funding round 68 years after it was founded.

Where is Aceto located?

Aceto is headquartered in New York, United States. It is registered at New York, New York, United States.

What is the annual revenue of Aceto?

Annual revenue of Aceto is $42.29M as on Mar 31, 2023.

What does Aceto do?

Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.

Who are the top competitors of Aceto?

Aceto's top competitors include Concord Biotech, Almac Group and Indoco Remedies.

What products or services does Aceto offer?

Aceto offers Analytical Services, GMP Contract Manufacturing, and R&D Services.

Is Aceto publicly traded?

Yes, Aceto is publicly traded on NASDAQ under the ticker symbol ACET.

How many acquisitions has Aceto made?

Aceto has made 8 acquisitions, including A&C, A&C Bio Buffer, and Biotron Laboratories.

What is Aceto's ticker symbol?

The ticker symbol of Aceto is ACET on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available